MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-10-31.

Income Overview

Net Income
-$49.868K
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-10-31
2025-07-31
2025-04-30
Sales
0 0 -
General and administrative
16.102 2 11.453
Professional fees
23.094 33 49
Total operating expenses
39.196 35 60.453
Loss from operations
-39.196 -45 -60.453
Gain on extinguishment of debt
-1 -
Interest expense
10.672 5 5.31
Total other expenses
-10.672 0 5.31
Net loss before tax provision
-49.868 -45 -65.763
Tax provision
0 0 -
Net loss
-49.868 -45 -65.763
Basic and diluted
--35,327,050
Net loss per common share basic and diluted
0 -0.003 -
Weighted average common shares outstanding - basic and diluted
38,962,050 8,779,452.75 -
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$49.868K Net loss before taxprovision-$49.868K Total other expenses-$10.672K Loss from operations-$39.196K Interest expense$10.672K Total operatingexpenses$39.196K Professional fees$23.094K General andadministrative$16.102K

Quantumzyme Corp. (QTZM)

Quantumzyme Corp. (QTZM)